The U.K.'s Acambis has won a $425 million contract to supply the CDC with its smallpox vaccine for 10 years. Acambis will establish a U.S.-based manufacturing capability for ACAM2000 and deliver a minimum of nine million doses per year of the drug. "The net proceeds will enable us to invest in manufacturing facilities for the U.S. contract, progress our vaccine for hospital-acquired C.difficile infections and further our program of new vaccines against influenza, genital herpes and other significant unmet medical needs," Acambis head Ian Garland told ShareCast.
- see the Acambis release [1]
- read this report [2]Â from ShareCast
Related Articles:
Sanofi buys into Acambis' West Nile vaccine program [3]
Acambis' universal vaccine begins human clinical trials [4]
Acambis shares plunge after U.S. nixes contract [5]
Acambis completes vaccine BLA [6]
Acambis researching single-shot solution to flu [7]
Links:
[1] http://www.fiercebiotech.com/press-releases/425m-ten-year-acam2000-smallpox-vaccine-contract-awarded
[2] http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=2059561
[3] http://www.fiercebiotech.com/story/sanofi-buys-acambis-west-nile-vaccine-program/2007-11-13
[4] http://www.fiercebiotech.com/story/acambis-universal-vaccine-begins-human-clinical-trials/2007-07-17
[5] http://www.fiercebiotech.com/story/acambis-shares-plunge-after-u.s.-nixes-contract/2006-11-14
[6] http://www.fiercebiotech.com/story/spotlight-acambis-completes-vaccine-bla/2006-04-19
[7] http://www.fiercebiotech.com/story/acambis-researching-single-shot-solution-to-flu/2005-08-04